pharma · Asthma · Respiratory Syncytial Virus Infections
GSK Glaxo Smith
GlaxoSmithKline
GSK Glaxo Smith clinical programs — 70 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 637 r Aulnois, Saint Amand les Eaux, 59 59230, FR, SAINT-AMAND LES EAUX
- Employees
- 30
- Programs
- 205
- Drugs
- 194
- Patents
- 0
GSK Glaxo Smith projects
70 ClinicalTrials.gov programs sponsored by GSK Glaxo Smith.
GSK Glaxo Smith has 70 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
JEMPERLI 500 mg concentrate for solution for infusion
GlaxoSmithKline
Neoplasms, Head and Neck
1 trial -
Locally Sourced 0.9% Sodium Chloride
GlaxoSmithKline
Dermatitis, Atopic
1 trial -
Locally Sourced 0.9% Sodium Chloride
GlaxoSmithKline
Dermatitis, Atopic
1 trial -
NaCl 0.9% solution
GlaxoSmithKline
Meningitis, Meningococcal
1 trial -
NaCl solution
GlaxoSmithKline
Herpes Simplex
1 trial -
Other: Placebo
GlaxoSmithKline
Menopausal and Female Climacteric States
1 trial -
Placebo for GSK5784283.
GlaxoSmithKline
Asthma
1 trial -
Placebo to Match GSK3915393 Tablet
GlaxoSmithKline
Idiopathic Pulmonary Fibrosis
1 trial -
Placebo to Match GSK3965193 Tablets
GlaxoSmithKline
Hepatitis B
1 trial -
Reblozyl 75 mg powder for solution for injection
GlaxoSmithKline
Myelofibrosis
1 trial -
Rotarix™
GlaxoSmithKline
Infections, Rotavirus
1 trial -
SB497115
GlaxoSmithKline
Thrombocytopaenia
1 trial -
SB497115
GlaxoSmithKline
Purpura, Thrombocytopaenic, Idiopathic
1 trial -
SERETIDE Rotacaps
GlaxoSmithKline
Asthma
1 trial -
SRA-MMB-4365/219627
GlaxoSmithKline
Primary Myelofibrosis (PMF), Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
1 trial -
Solabegron
GlaxoSmithKline
Overactive Bladder
1 trial -
albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
dabrafenib
GlaxoSmithKline
Solid Tumours
1 trial -
meningococcal ACWY (vaccine)
GlaxoSmithKline
Infections, Meningococcal
1 trial -
pazopanib (GW786034)
GlaxoSmithKline
Neoplasms, Uterine Cervix
1 trial -
pazopanib (GW786034) 400 mg
GlaxoSmithKline
Neoplasms, Breast
1 trial -
sterile saline solution (0.9% w/v solution of NaCl in water).
GlaxoSmithKline
Urinary Tract Infections
1 trial
Frequently asked questions
How many clinical projects does GSK Glaxo Smith have?
70 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.